Physician profile
Keith A Mayo
NPI 1972510014
$3,101,469.92
in general payments reported to CMS, 2019-2025
5 companies · $334K in 2025
The $334K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $427K · 2020: $625K · 2021: $475K · 2022: $444K · 2023: $405K · 2024: $391K · 2025: $334K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.1M · Consulting Fee: $18K · Travel and Lodging: $14K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $7,000 · Honoraria: $3,488 · Food and Beverage: $1,478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,086,071.74 |
| Consulting Fee | $18,056.95 |
| Travel and Lodging | $14,086.89 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $7,000.00 |
| Honoraria | $3,488.00 |
| Food and Beverage | $1,477.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $2,975,903.94 | 2019-2025 | Lcp, Na |
| Synthes Gmbh | $72,716.35 | 2019-2025 | |
| Medical Device Business Services, INC. | $30,439.91 | 2019-2024 | Na |
| Depuy Synthes Sales INC. | $22,306.73 | 2024-2025 | Tfn-Advance, Na, Va-Lcp |
| Next Science LLC | $102.99 | 2023 | Surgx, Xperience, Blastx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Mayo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.